Losartan Market to Grow at a Rate of 7.81% During 2026
Growing prevalence of hypertension
is expected to drive the growth of the Global Losartan market.
According to
TechSci Research report, “Global Losartan
Market By Source (Contract Manufacturing Organizations, In-House), By Form
(Tablet, Powder), By Strength (25mg, 50mg, 100mg, Others), By Distribution
Channel (Offline, Online), By Application (Hypertension, Stroke, Diabetic
nephropathy, Others), By End-User (Adult, Pediatric), By Region, Forecast &
Opportunities, 2026”, the Global Losartan market
is expected to grow at a steady rate of 7.81% during the forecast period. The Global
Losartan market was valued at USD4.73 billion in 2020. Losartan is an
angiotensin II receptor blocker and is available as losartan potassium oral
tablets as well as a combination tablet of losartan potassium and
hydrochlorothiazide. The consumption of Losartan also delays the progression of
diabetic nephropathy which is expected to fuel the market growth through 2026. However,
side-effects associated with drug consumption also delay the progression of
diabetic nephropathy can restrict the market growth over the next few years. Along
with this, patients suffering from type 2 diabetes and kidney disease may
experience diarrhea, low blood pressure, fatigue, low blood glucose, chest
pain, elevated potassium, or allergic reaction. This can further reduce the
usage and application of the drug, thereby hindering the market growth during
the forecast period.
Browse 293
market Figures spread through 110 Pages
and an in-depth TOC on “Global
Losartan Market”
https://www.techsciresearch.com/report/losartan-market/7269.html
The Global
Losartan market is segmented based on source, form, strength, distribution channel,
application, end user, company, and region. Based on application, the
market can be fragmented into hypertension, stroke, diabetic nephropathy, and others.
The hypertension segment is expected to dominate the market in the forthcoming
years on account of the rising count of patients having high blood pressure
problems in the country. Based on source, the market can be categorized into in-house
v/s contract manufacturing organizations. Among these, the in-house segment is
expected to witness the fastest growth in the forecast period. In terms of form,
the market is split into tablets and powder. Among them, the tablet segment is
projected to grow at a high rate in the next five years on account of multiple
benefits it provides such as ease of availability, affordable price, etc. Also,
they offer faster relief from symptoms when compared to powder. This is further
contributing to its fast-growing CAGR in the years to come. Based on strength,
the market is segmented into 25 mg, 50 mg, 100 mg and others. Among these, the
25 mg segment is expected to dominate the market because of the higher demand
and supply of these tablets. Furthermore, the market can also be segmented on
the basis of distribution channel which is categorized into offline and online.
The offline segment is leading the market and is expected to maintain its
position in the coming years as well. The prime reason for the higher share of
offline sales is due to Losartan being a prescribed medicine which is not
available over the counter without the doctor’s prescription. Apart from this,
the market is also segmented on the basis of end-user which is sub-segmented
into adult and pediatric. The adult segment is leading the market and is
expected to maintain its lead in the forecast period as well.
Merck & Co.
Inc., Pfizer Inc., Teva Pharmaceutical Industries Ltd., Sanofi S.A., Novartis
International AG, Dr. Reddy’s Laboratories Ltd., Sun Pharmaceuticals Industries
Ltd., Aurobindo Pharma Ltd., Torrent Pharmaceutical Ltd., Lupin Ltd., Mylan
N.V., Ipca Laboratories Limited, Macleods Pharmaceuticals Limited, Abbott
Laboratories, Cadila Healthcare Limited, and others are some of the
leading players operating in the Global Losartan market. Companies operating in
the market are using organic strategies such as product launches, mergers and
collaborations to boost their share and increase their geographic reach.
Download
Sample Report @ https://www.techsciresearch.com/sample-report.aspx?cid=7269
Customers can also request for
10% free customization on this report.
“Global Losartan market is
expected to witness growth during the forecast period as it is used to treat hypertensive
patients with left ventricular hypertrophy. Further, it
reduces the risk
of stroke in patients having high blood pressure problems which is further
expected to create lucrative opportunities for the market growth of the Global
Losartan market over the next five years.” said Mr. Karan Chechi, Research Director with
TechSci Research, a research based India management consulting firm.
“Global Losartan Market By Source (Contract
Manufacturing Organizations, In-House), By Form (Tablet, Powder), By Strength
(25mg, 50mg, 100mg, Others), By Distribution Channel (Offline, Online), By
Application (Hypertension, Stroke, Diabetic nephropathy, Others), By End-User
(Adult, Pediatric), By Region, Forecast & Opportunities, 2026” has evaluated the future growth potential of the Global
Losartan market and provides statistics and information on market size,
structure and future market growth. The report intends to provide cutting-edge
market intelligence and help decision makers take sound investment decisions. Besides,
the report also identifies and analyzes the emerging trends along with
essential drivers, challenges and opportunities in the Global Losartan market.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email:
[email protected]